Item 1. Election of Officers
Chair: Chair: It’s a great honour to welcome you to the 69th session of the CND and for me to chair the CND. It’s the first time that Armenia holds the chair over CND and I would like to thank you for the support and trust. No country can tackle the world drug problem alone. Close international cooperation among all stakeholders, including member states, civil society and the private sector is essential. The CND has served as the central forum in the UN for shaping international drug policy and advancing cooperation. I look forward to working closely with all member states and our stakeholders to advance our shared objectives. We will address some procedural and organisational matters. I would like to thank my colleagues in extended Europe. In accordance with the economic and social council the commission elected the officers.
Chair – Andranik Hovhannisyan (Armenia)
First Vice-Chair – Peter Christiaan Potman (Kingdom of the Netherlands)
Second Vice-Chair – María Eugenia Echeverría Herrera (Peru)
Third Vice-Chair – Maimounata Ouattara(Burkina Faso)
Rapporteur – Vikram Jeet Duggal (India)
Item 2. Adoption of the agenda and other organizational matters
Chair: The annotated provisional agenda and proposed organisation of work are contained in the document. The Council has approved the provisional agenda. I would like to share the following information: the agenda is structured into two distinct operational and normative segments. Voting by the members must be in person. The commission will consider the recommendations resulting from the 48th meeting of a WHO expert committee. As no consensus was reached by last Friday 6th of March the selection will need to happen by secret ballot in accordance with rule 66 and 67. After elections happen we will return tomorrow morning to Agenda Item 3 and finish the list of speakers for general debate and other sub items under Agenda Item 5, before we return on Friday to Agenda Item 12, Adoption of Report. Now, regarding the CoW, it will be chaired by ambassador Peter Christiaan Potman, permanent representative of the Netherlands. Five proposals were tabled. Delegations had the opportunity to present them during the informal precession consultation. There are constraints on the availability of interpretation due to the liquidity crisis of our regular budget. The committee of the whole will happen without interpretation. We are at a very serious financial constraint affecting the provision of conference services. I thank delegations for their support. Can I invite the commission to adopt the provisional organisation of work. I see the US.
US: Chair, the US objects to the title of agenda item 9 of the provisional agenda because it contains reference to the 2030 agenda for sustainable development. We have repeatedly noted the US will no longer affirm it as a matter of course. The US aims to ensure CND’s delivering on its mission to combat rapidly evolving complex and global. We propose an amendment in the title of this agenda item to delete the phrase, including follow-up and review and implementation of the 2030 agenda for sustainable development.
Chair: Thank you, your request will be duly noted. I ask the secretariat to project the oral amendment. In accordance with rule 64, CND will first take a decision on the amendment made. May I take it the commission wishes to adopt the amendment submitted by the US.
France: I would like to underscore our commitment to ensuring the 2030 Agenda and we are convinced CND plays a key role in achieving SDG 3. These health goals can be realised if we set up a prevention system to reduce risk through prevention of consumption. Our view is that continuity between SDGs and safety of countries so we should retain reference to SDGs
Argentina: We would like to support the amendment to Agenda Item 9 regarding the annotated provisional agenda for the meeting. For the same reasons presented by the US. We made the same motion at last year’s meeting and maintain this position. It is not relevant and my government has said that agenda 2030 is entirely voluntary and should not be included in this meeting.
Colombia: We support France and believe the 2030 Agenda is an integral part of CND agenda.
Brazil: We would like to add our voice to France and Colombia in maintaining the language that refers to the 2030 Agenda.
South Africa: My delegation would also support the retention of the SDGs in this agenda item.
China: We also support the statements made and we hope to retain the current wording of Agenda Item 9. We also believe this is the view of the majority of member states.
Chair: There is clearly no agreement among the commission.
United States: We would like to call a vote on our proposed amendment.
Chair: We will now commence with the process of voting. In accordance with Rule 61 no representative may interrupt voting except on a point of order related to the voting process. Simple majority present and voting is required. Present and voting means members casting affirmative or negative vote, abstentions count as not voting.
In favour: Argentina, United States of America, Bolivia
Against: Armenia, Australia, Austria, Belgium, Burkina Faso, Chile, China, Colombia, Côte d’Ivoire, Dominican Republic, Finland, France, Germany, Ghana, Guatemala, Honduras, Hungary, India, Indonesia, Italy, Kazakhstan, Kyrgyzstan, Lithuania, Malta, Mexico, Morocco, Netherlands, Nigeria, Pakistan, Peru, Poland, Portugal, Qatar, Singapore, Slovenia, South Africa, Spain, Switzerland, Thailand, Ukraine, United Kingdom, Tanzania, Uruguay, Zimbabwe
Abstention: Japan, United Arab Emirates
Chair: 3 in favor, 45 against, 2 abstentions. The Commission rejects the amendment. Let us return to adoption of the agenda. Can I propose for the commission to adopt the agenda? It is decided. Can I propose for the commission to adopt the organisational arrangements? It is decided. I have the pleasure now to introduce the ECOSOC President.
ECOSOC President: At a time of uncertainty the world drug problem is more complex and dangerous with a profound impact. This can’t be addressed in isolation, it intersects with health, human rights, education, equality, and peace. The drug market is more dynamic and adaptive, synthetic drugs are expanding at unprecedented speed with consequences for public health. Trafficking fuels crime and violence, affecting particularly women, youth and marginalized communities. CND plays a more critical role than ever. Through your work you advance evidence based and balanced processes through development and human rights and ensure policy is grounded in data, research and evidence. ECOSOC 80th anniversary and theme of work is building a sustainable future for all. Commitment to the high level forum on sustainable development is vital. This coincides with opportunities to strengthen and ensure work remains fit to address future challenges. Next year ECOSOC will review the work of bodies and draw on the conclusion of the General Assembly review of ECOSOC to ensure alignment and coherence. We stand ready to champion CND work to strengthen architecture for substantive input. Communities count on your leadership. I wish you fruitful discussions.
UNODC: Let me begin by congratulating our new chair—I know you will guide us to a successful conclusion. It is encouraging to see so many people in this room ready to work together toward a world that is healthier and safer from illicit drugs. We have over 2,200 registered participants and representatives from 127 member states. We will miss some colleagues unable to join us due to global developments. At a time of multiple crises, your presence sends a powerful message: we cannot relent in addressing the challenges and harms posed by illicit drugs. You are showing that the international community remains committed to tackling the world drug problem. Drug markets are adapting and organizing, and criminal networks are looking to exploit new opportunities. The speed and scale at which this happens is new, driven by the expansion of synthetic drugs that can be manufactured and trafficked anywhere. Seven hundred and twenty-six unique substances were detected last year—the highest number ever in a single year—including nitazenes, and overdoses are intensifying as a challenge to public health. Global cocaine production and trafficking are at record levels, and criminal networks are increasingly sophisticated, using tools like the dark web to evade detection. All of this comes at a profound human cost. Last year’s World Drug Report showed that over 316 million people used drugs in 2023, and 64 million suffered from substance use disorders—yet only 1 in 12 are in treatment. Women face particular barriers, with only 1 in 18 receiving treatment. People who inject drugs also face a high risk of HIV. We cannot afford to take our eyes off the world drug problem. The financial situation is stretching capacities across the UN, including here, and it continues to deteriorate and will only worsen. But we are resilient, and I am confident with your support. We are ready to welcome the new Executive Director, Monica Juma,—I am sure she will provide fresh leadership and vision given her experience. We are looking at different ways to work better and deliver our mandates more effectively. We are developing new strategies and engaging in the UN80 reform process. Our technical delivery exceeded $380 million. That support translated into tangible impact and facilitated the seizure of 168 tons of cocaine and 400 tons of precursor chemicals. Last year, we provided technical assistance to coordinate joint operations. We continue to invest in prevention, health, and alternative livelihoods.
WHO: The international community faces unprecedented challenges. Funding cuts, conflicts, and geopolitical tensions are limiting our ability to meet urgent health and social needs. An estimated 64 million people worldwide live with drug use disorders, and hundreds of thousands die each year from preventable harms linked to drug use. These lives can be saved with evidence-based measures, including prevention, treatment, and harm reduction. Yet access to these interventions remains very limited. Access to controlled medicines also remains inadequate, including for palliative care, mental health conditions, and substance use disorders. The World Health Organization provides scientific advice to support decisions on international drug control, but international scheduling is only one part of our responsibility. Countries must also ensure that controlled medicines are available for medical and scientific use. I urge all countries to advance balanced, evidence-based policies that protect health, reduce harms associated with drug use, and ensure access to essential medicines. At a time when solidarity is critical, multilateral cooperation is indispensable. Thank you for your partnership on this difficult but important issue. The World Health Organization remains committed to working with all of you to advance people-centred drug policies grounded in public health and human rights.
INCB: I want to congratulate you on your election and also welcome the new Executive Director of UNODC. I will be presenting the INCB reports for 2025, a year marked by extensive discussion on how the UN can continue delivering for the people it serves. The report focuses on international cooperation in drug control and represents a success for that cooperation, with low levels of diversion. Despite disparities in the availability of controlled medicines, global supplies are sufficient to meet national requirements. Another success is the international control of the precursor chemical piperidone—if a single shipment had not been stopped, it could have been used to manufacture up to 1.6 million doses of fentanyl. The work of the INCB programmes has also yielded results: governments have exchanged information on more than 135 seizures, intercepting over 1.5 million individual doses. INCB is proud of these achievements, made together with member states, international organizations, and civil society. However, a lack of stable and predictable funding persists. The liquidity crisis is affecting our mandated functions. The INCB precursor programme and learning programme rely on voluntary contributions. We are grateful to those who have made voluntary contributions to ensure our work can continue, and we invite member states to consider contributing so that the international control system can continue to safeguard health and welfare worldwide. The year 2026 marks the tenth anniversary of the General Assembly special session on the world drug problem. The outcome document from that session remains as relevant as ever—if not more so—reinforced by the 2019 Ministerial Declaration. In the 2024 High-Level Declaration, the international community advances its efforts to implement these shared commitments.
Item 3. General debate
Chair: I urge all delegations to respect speaking times especially in light of reduced interpretation services I first invite
Group of 77 and China: We thank India for chairing this session. The Group pledges its full cooperation to the Chair and expresses appreciation for the organization of the session. We reaffirm the role of the CND as the principal policymaking body of the United Nations, with primary responsibility for drug control matters, and recognize the efforts of all entities in addressing the world drug problem, which is a common and shared responsibility. This responsibility should be undertaken through a multilateral, integrated, and comprehensive approach to promote the health, security, and safety of humanity. We stress the importance of international cooperation and capacity-building efforts, particularly for developing countries. We express concern regarding financial constraints that affect the provision of technical assistance and capacity-building. We underscore the important role of all stakeholders and reiterate the three UN drug conventions. We reaffirm our commitment to ensure that all aspects of demand and supply reduction are addressed. Efforts to achieve the Sustainable Development Goals are complementary to addressing the world drug problem. We reaffirm our commitment to prevent, reduce, and eliminate illicit cultivation, production, manufacturing, and trafficking. We note with concern the diversion of illicit drugs and precursors and money laundering. We also note with concern the disparities in progress regarding access to substances for medical and scientific purposes, as well as the unmet demand for treatment of drug use disorders. We recognize the importance of increasing efforts to promote viable economic alternatives. We acknowledge that states most affected by drug transit, particularly developing countries, have made significant contributions and sacrifices. We express concern regarding the proliferation of synthetic drugs and urge all member states to take action to address this challenge. We reaffirm our commitment to implement tangible measures to counter criminal organizations involved in illicit drug trafficking, addressing drug abuse, violence, and social harms, while upholding the rule of law. (The full G77 statement should be available here: https://www.g77.org/statement/)
Group of African States: We align with the statement of the G77 and China. We uphold the spirit of consensus and reiterate our resolve to review the drug policy commitments and accelerate implementation until 2029. We support UNODC efforts through the Strategic Vision for Africa 2030 and call for sufficient funding. CND is the prime UN policy making body and we reaffirm the treaty mandated roles of UNODC, INCB and WHO. We uphold the principles of common and shared responsibility and reiterate commitment to the Ministerial Declaration of 2014, 2016 UNGASS Outcome Document, 2019 Ministerial Declaration and High-Level Document of the 2024 Mid-Term Review. We express concern about humanitarian emergencies, including in Gaza, and must ensure the availability of medicines. We are concerned about the availability of medicine for medical and scientific purposes. Need concrete measures to maintain access to controlled medicines. Deeply concerned about proliferation of substandard and falsified medical products in Africa. Support member states to strengthen measures to counter this challenge. We are concerned about synthetics and impact on the illicit drug market. We register concern about the link between trafficking and other transnational organized crime. We are committed to enhancing regional and international cooperation to tackle this. Early intervention under convention on cyber crime which ensures sharing of evidence. Enhanced technical assistance and capacity building is essential to achieving the SDGs. We need to mainstream gender and age perspectives into drug related policies. We are concerned about the increasing non medical use of opioids, including tramadol, and need to share information on its non medical use while ensuring medical access. Ensure supply and demand reduction and address drug use as a health and social issue. Need adequate resources to implement the mandates. Adapting to financial limitations should not negatively affect capacity building and technical assistance. Inadequate implementation of the principle of geographic representation and need more UNODC personnel across the African continent. Remain committed to a rounded approach to tackling the world drug problem based on common and shared responsibility.
Group of Asia-Pacific States: We align with statements from G77 and China. Extend full support to the UNODC and look forward to working with you to strengthen the spread of illicit drug use. Affirm our position that UNODC is the leading entity in the UN system to address the world drug problem and CND has the principle role of guidelines on drug matters. The world drug problem remains a challenge to be addressed in a multilateral setting. Support efforts aimed at regional and international cooperation and coordination. Commitment to ensure that all efforts to address the world drug problem including supply and demand reduction. Cooperation undertaken with alignment with UN charter, international law and UN Declaration on Human Rights. Respect for sovereignty and non intervention in internal affairs and fundamental freedoms among states. We acknowledged efforts to promote economic alternatives to drug related activities. The three drug control conventions constitute the cornerstone of the drug control system. It is vital to comply with these conventions. We underline complementary and reinforcing nature of 2009 and 2014 Ministerial Declarations, 2016 UNGASS Outcome Document, 2019 Ministerial Declaration, and 2024 Mid-Term Review. We fully support all efforts to strengthen cooperation for countering production and trafficking of drugs and diversion of scheduled chemicals. We commit to working towards universal access to prevention and treatment programs and related services in full compliance with conventions and national legislation. Finally we need to address the needs of those most affected by the world drug problem, especially women, children, and youth to promote balanced policies.
Group of Latin American Countries and the Caribbean (GRULAC): We are ready to work actively in CND. We support UNODC Acting Executive Director John Brandolino and thank the secretariat for their work in difficult circumstances. We reiterate our determination in line with declarations and mid-term reviews. We acknowledge challenges and align with drug treaties which provide flexibility to states. The world drug problem is a joint and shared responsibility that requires a multilateral framework and should be carried out in conformity with international law, human rights, and notably respecting sovereignty and territorial integrity and the principle of non-intervention on domestic affairs, equality and respect. Progress made by the world drug problem continues to have an impact on public health, safety, and wellbeing and the environment. Expansion of markets boosted by growing demand and criminal gangs. We need to build capacity to prevent, detect and penalize these criminal organizations. Growing link between trafficking and other crimes such as firearms, environment crimes and money laundering which have an impact on the population. More comprehensive response to illicit economies bearing in mind their impact. We acknowledge importance of increasing efforts for economic alternatives through comprehensive Alternative Development programmes that include preventive Alternative Development programmes in rural and urban areas and we are concerned with growing use of psychoactive and synthetic drugs and need specific solutions to these emerging challenges. Strengthen cooperation and access to resources without restrictions to deal with the world drug problem and welcome World Drug Report 2025 and appreciate efforts. The methodologies could be improved regarding statistics and information to effectively reflect reality and local context. Progress made in establishing expert panel in CND Resolution 68/6 with recommendations to strengthen the drug control system to be reviewed in 2029. Concerned with financial limitations and efforts to adapt won’t have impact on governing bodies and technical assistance and capacity building. It is important to have simultaneous interpretation and right conditions for achieving aims. Maintain LAC as a zone of peace with differences solved through dialogue and other peaceful measures.
European Union: This year marks 10 years since 2016 UNGASS on the world drug problem and adoption of its outcome document. The principles remain valid. This milestone is a stark reminder of progress achieved and the magnitude of challenges. The world drug problem is complex, evolving, and interconnected. Mulitalateralism and cooperation is more important than ever. Central role of CND as principal UN body along with the work of UNODC. EU and member states address the world drug situation through evidence based and human rights centered approach, based on international law and in compliance with conventions. This approach is reflected in EU drug strategy. Preparedness for response to health, social, and security challenges. Strengthen information exchange and capacities. People and public health are at the center. Prioritises evidence based and early intervention including risk and harm reduction with aim of reducing health and environmental drug related harm. Gender responsive responses and improved access for vulnerable groups. Strengthen security and protect society, reducing supply. Trafficking represents a persistent threat. Over half of criminal groups in the EU are involved in drug trafficking through violence, corruption, and involvement in the legal economy. Dismantle organised network and disrupting financial flows to prevent infiltration in key ports and preventing synthetic drugs and precursors. EU action is firmly grounded in international law and control conventions. Implemented in line with human rights law and with respect for international law. Policies must uphold human rights including the right to life, health, human dignity and the principle of proportionality. Oppose the use of the death penalty in all cases and all circumstances, including for drug offences and we call for its abolition. We renew our commitment to strengthen collaboration to address the world drug situation globally and to bring forward in multilateral fora. Resolution 68/6 prepares for the 2029 Ministerial Conference and we attach great importance to this work and we present highly qualified candidates from Belgium, Portugal, Latvia and Czechia and we appreciate support for their candidates. We bring forward a balanced and evidence based response which places health and security on equal footing and based in cooperation.
Chair: This concludes the statements of representatives of regional groups but before going to list of speakers of high level speakers, I would announce we will have the presence of Gustavo Petro, president of Colombia. Now to high-level speakers, it’s my pleasure to invite Bolivia.
Bolivia: Bolivia reaffirms its commitment to the international drug control system and the principle of joint and shared responsibility. The world drug problem is complex, linking public health, security, sustainable development, financial stability, and governance. Criminal organizations diversify markets, exploit loopholes, and engage in money laundering, weapons trafficking, human trafficking, environmental crimes, and smuggling. We need comprehensive responses. Bolivia’s anti-drug policy is based on five pillars: 1) strengthening institutional capacity and international cooperation, improving operational, technological, and intelligence capacities, and coordinating regionally and internationally against organized crime.2) responsible control of coca leaf crops, monitoring, traceability, and reducing diversion to illicit markets, while promoting sustainable alternative development with UNODC. 3) strategic planning and operational efficiency,using technology, analysis, and regional cooperation to anticipate organized crime trends. 4) prevention and treatment policies, focusing on public health, especially vulnerable populations like youth and women, and updating the national demand reduction plan. 5) International cooperation and financial integrity, dismantling finances of criminal networks is as important as intercepting drugs. Bolivia believes policies should be science-based, respect cultural diversity, and follow the drug conventions. The key challenges today are synthetic drugs, chemical precursors, and global supply networks. Bolivia will continue acting responsibly, combining security, public health, sustainable development, and multilateral cooperation. The international system’s stability depends on adapting intelligently, maintaining consensus, and strengthening cooperation among states. Thank you.
Malta: Malta aligns with the statement of the European Union and reaffirms its commitment to the international drug control framework and the full implementation of agreed drug policy commitments to protect public health. This approach is evidence-based, human rights-centered, and embedded in our national drug policy. Over the past year, we strengthened our holistic response to drug use disorders through the National Drugs and Education Unit, which coordinates monitoring, housing, and national capacities to address evolving challenges. We also launched the non-communicable diseases prevention framework 2025–2035, prioritizing prevention, early diagnosis, and long-term coordinated care for vulnerable groups. Malta has made PrEP and PEP freely accessible to enhance HIV prevention, including for people who use drugs, and is actively working to eliminate hepatitis C, with current cases reduced to around 800. Essential services provided include opioid agonist therapy, counseling, rehabilitation, and other recovery support services. National legislation has been amended to prioritize treatment and rehabilitation over imprisonment for non-violent drug offenders. Malta invites all to its side event on health, justice, and people-centered drug policy, Wednesday, 11 March, at 3 PM. Malta reaffirms its commitment to the four-pillar approach to drug policy and the 2030 Sustainable Development Goals, emphasizing people-centered policies. Finally, Malta announces its candidacy for the Commission on Narcotic Drugs for the term 2028–2031, seeking continuity and consolidation of its work on international drug policy through multilateral cooperation. Thank you.
Belgium: Belgium aligns with the EU statement. We’re facing a deepening drug crisis that needs a comprehensive, coherent response. Our new strategy is grounded in public health, human rights, and evidence-based. We’re advancing coordinated initiatives for people who use drugs, including better healthcare in prisons and collaboration between police and health services. We’re concerned about illegal vapes among youth, which we’ll address in our side event. Belgium remains committed to improving international access to controlled substances, while addressing security challenges from drug-related crime. We’ve intercepted significant cocaine shipments and seen more marijuana seizures. Our strategy focuses on three things: 1 strengthening protection of points of entry, 2) dismantling criminal economic models by targeting financial structures 3) enhancing data sharing and analysis. We’re upgrading our legal framework introduced more severe penalities or organized crime and are committed to restorative justice for vulnerable minors and youth recruited by criminal networks. National efforts alone aren’t enough, so we’re cooperating with partner countries, especially in Central and Latin America, and contributed 500,000€ to a UNODC project supporting legal reforms there. We reaffirm support for the CND’s central role, global drug policy, and SDG goals. We’ve nominated Mr. Alexis to the multidisciplinary expert panel and encourage support for his candidacy. Thank you.
Italy: aligns with the EU statement. 2025 was a pivotal year domestically. On 7 November in Rome, a national conference on addictions brought together public and private practitioners and high-level national authorities. It was enriched by video message from the former Executive Director of UNODC, Ghada Waly. Italy opposes the use of narcotic drugs for nonmedical purposes and does not recognize a legal right to use drugs. Our commitment is to act before harms become irreversible and to expand spaces free from drugs, guided by responsibility towards future generations. The synthetic drug market continues to grow, with psychoactive substitutes that are highly dangerous and easy to produce. Distribution is rapid and increasingly online. Italy has strengthened prevention and monitoring efforts, including the National Prevention Plan against synthetic opioids. We also reinforce international cooperation, providing specialized training for law enforcement in Central and South America, in partnership with COPOLAD and Interpol. Public and private workers and residents of therapeutic communities, including people in detention, are part of recovery programs. We cannot remain silent in the face of drug-related harms among youth and the human need for hope and meaning. Italy remains fully committed to this global effort.
United States: I join you all today not only to speak for the United States of America, but to give a voice to the mothers and fathers of murdered children. The families torn apart, the communities ravaged. And the millions of Americans who cannot join us today because their lives were cut short by illicit drugs. But now, under President Trump’s leadership, we are saving lives. And driving a stronger global response against the terror of drugs. For example, Operation Southern Sphere in the Caribbean Sea and the successful apprehension of the dictator Maduro has brought the world’s attention to the Western Hemisphere. And we are not alone in our strengthened efforts. Our neighbors and allies are joining us. To banish these poisons from our streets, our communities, and our homes. We are working together to protect our children from those who value profit over life. I recently participated in an event in Florida that shows this renewed cooperation. In Miami, our Secretary of War, Pete Hegseth, convened a meeting with military and security leaders of the Western Hemisphere to discuss how we can further our work to take down the cartels. A reinvigorated collaboration also comes after Mexico’s elimination of El Mencho, a notorious cartel leader. Despite their successes, our friends and neighbors took significant losses. I joined the government of Mexico, and the families of the fallen, in their grief. Thank you. And my heart weeps for families across the region whose lives were taken too soon by cartel violence. But now we must double down. We must bring the fight to where these criminal networks stash their poisons, store their money, ship deadly inventory, and feel the safest. Last year, we seized over 47 million fentanyl-laced counterfeit pills and nearly 100,000 pounds of fentanyl powder coming into our country. Representing almost 369 million lethal doses. Yet almost 80,000 American lives were lost to drug overdoses and poisonings. This includes cocaine and methamphetamine laced with illicit fentanyl. In response, the US has designated fentanyl and its precursors as weapons of mass destruction. Cartels and dealers see fentanyl as a way to boost profits, even at the risk of customers dying. Because adulteration with this substance enhances addiction. These bad actors are waging a chemical war. they fight easily by exploiting minimal regulations on fentanyl and other deadly precursors. But we know where the precursors come from. They are manufactured in the millions of tons in China. We know they move through the global supply chain. China’s weak export controls and lack of enforcement allow its chemical industry to foster friendships with cartels. At the same time, China’s overly strict controls on rare earth minerals hurt legitimate industries. We are working tirelessly to halt the trade of precursors at the source. Not only to protect American lives, but to protect the lives of people worldwide. This forum is a chance for nations to band together. To combat not just narcotics, but criminal enterprises and their funding. Their allies in power disrespect the law, terrorize citizens. They don’t play by rules. They answer to no one. But our advantage is our ability to work together, respect the law, leverage our citizens’ talents and good character, and focus our might to target those causing this deadly destruction. If our goal is truly a peaceful world and a thriving, healthy citizenry, we cannot let the cancers that aim to destroy us continue to prosper.
Kazakhstan: We share concerns and restate our commitment to the international drug control conventions. Crucial to eliminate trafficking to uphold safety, law, and order. We are at the intersection of transit routes and there are vast territories in our country where cannabis grows naturally. We have pulled together the efforts of all law enforcement agencies and developing international cooperation and rolling out digital tools. In line with following the money we have established a system for seizing money derived from trafficking – we have seized money, crypto, and frozen accounts, and placed restrictions on foreign accounts and requested assistance from partners. We have thwarted efforts of criminal groups and shut down trafficking routes, removed 147 tonnes of drugs including synthetics and heroin, as well as cocaine. Especially important to have high level cooperation and mutual understanding. Fully support strengthening cooperation and enhancing control systems. We endorse all initiatives to combat scourge.
Singapore: The world drug problem is worsening. The number of people using drugs is increasing. Methamphetamine is a serious concern for East and South East Asia, accounting for 70% of all people undergoing treatment in the region. No country can tackle the world drug problem alone and we are committed to working with the international community to address this issue. We stress the importance of the conventions and mandates of the CND and mandates of INCB and UNODC. We support the review of substances and providing recommendations on international control. Last year Singapore announced candidacy for second term on CND for 2028-2031. We contribute constructively to evidence based policies including collaboration with UNODC and partners. We have and will sponsor thematic chapters in the World Drug Report. We invite delegations to our side event co-organised with UNODC to discuss the unforeseen health impacts of drug use. We work closely with regional partners and reaffirm our vision to drug free ASEAN. Commemorating ASEAN drug victims remembrance day on 26th June to raise awareness and strengthen the public against harms of drug use. Requires unwavering support and we stand ready to play a constructive role to catalyse action and protect the wellbeing of our people.
Armenia: Committed to multilateral cooperation and addressing the world drug problem. Continues to pose a threat to safety, security and sustainable development. Proliferation of synthetics and novel psychoactive substances coupled with exploitation of digital platforms and financial technologies continue to outpace enforcement. This is not within the power of and individual law enforcement or state. We are at the crossroads of Asia and Europe, we recognise our responsibility to contribute to combat trafficking and enhance international cooperation and control efforts. We contribute to efforts and frameworks to address synthetic drug threats like the Global Coalition to Address Synthetic Drug Threats. This is a deeply human problem affecting youth, families, and societies. Responses need to be balanced and humane. Real people that need support and treatment. Within our pledge of the 2019 Ministerial Declaration, we adopted efforts along with our action plan. This prioritised prevention, social reintegration, and provides gender and age responsive perspectives. Placed special emphasis on cooperation to facilitate exchange of best practice and strengthen technical and operational capabilities. Important role of member states as well as INCB and WHO to sustain commitment to principles of drug control framework and three conventions along with other relevant instruments.
China: Drugs are a scourge of society. We have worked hand in hand with the international community and worked with UNODC, INCB, and all parties to respond to drug matters. Zero tolerance attitude to illicit drugs and persevering in resolving the world drug problem. We have seen 27.6% decrease in drug related crimes. We have scheduled substances and precursor chemicals. Preventive education events including full coverage of anti-drug education. Effectively consolidating efforts of drug rehabilitation and monitoring drugs and psychotropic substances, including scheduling the entire class of nitazenes, becoming among the first countries to do so and effectively preventing risks. Enhance technology and steadfastly fulfill our responsibility to uphold rule of law and international treaties. We work with other countries to address challenges posed by synthetic drugs and contribute to the global efforts to combat the world drug problem. Certain countries use the world drug problem as a pretext for unilateral bullying and even interfere with internal affairs of other countries which harms international law and drug control. We should practice true multilateralism and uphold respect for countries sovereignty. We need to engage in international cooperation on equal footing rather than through abusing tariffs, sanctions, or shifting blame to other countries. It is regrettable that the US delegate made remarks not reflecting reality and these remarks are not constructive. We reject these remarks. Our common goal is to track down criminals and support each other. We hope the US can stop shifting blame to other countries. We suggest we should adopt a balanced approach through education, law enforcement, scheduling, and international cooperation to ensure minimising harm while respecting the rights of each country to explore control measures. We should strive to build a community free from the harm of illicit drugs. Side event on the use of synthetics among adolescents and we will also have an exhibition in the Rotunda and we welcome your participation. We continue to contribute to the noble cause of a world free from illicit drugs.
Uruguay: CND is a necessary forum to draw on responses to the evolution of the drug market and international organised crime that we are facing. Transformation of drug market and links to organised crime represent threat to social cohesion and rule of law. We require strong evidence based and innovative responses. Accept that prohibition and prohibition policies have not worked and led to overload of legal systems and social injustice. When things don’t work we need to review with responsibility. We need a comprehensive approach with people at the centre. We need to manage risk and not promote consumption but use scientific evidence and retain commitment to using international commitments in line with 2030 and the Sustainable Development Goals. Coherent policy in line with sustainable development should strengthen the rule of law and increase possibilities for most vulnerable members of society. We should decrease stigma and sanctions against people who use drugs and should not use prisons for minor offences. We are strongly against the use of the death penalty for drug related offences. We require effective institutions and cooperation with full respect for human rights. We welcome a review panel which will use evidence to draw up actions. We need to build consensus to have effective policies in line with international law.
Republic of Korea: My delegation acknowledges the contribution of UNODC in tackling the world drug problem through evidence-based policy, technical support, and capacity building. Despite global efforts, the situation is getting harder to contain. Organized crime is evolving, exploiting disruptions, and drug use is rising. UNODC’s 2025 report shows 316 million people used drugs in 2023, increasing 8% per year. Synthetic drugs are spreading and creating new challenges. Korea used to be drug-free but online trafficking through social media and the dark web has increased drug distribution and use. Korea adopted a National Plan in 2025, addressing both supply and demand, with law enforcement, prevention, treatment, rehab, and social reintegration. We prioritize international cooperation through the Anti-Drug Liaison Officers’ Meeting, the Asia-Pacific Info & Coordination Centre for Combating Drug Crimes, and the Asian Narcotics Crime Response Alliance, all helping info-sharing, capacity building, and joint investigations. Korea also partners with UNODC on alternative development programs in Colombia, Bolivia, and Afghanistan, and supports the Centre of Excellence for Statistics on Crime and Criminal Justice in Asia-Pacific. We remain committed to working with the international community on the complex challenges of the world drug problem, supporting collective efforts, and upholding the three international drug control conventions in close cooperation with UNODC.
Germany: The world is moving fast and pressure is growing. Success is not about speed, but precision. We need clarity in how we debate drug policy. Evidence must always be at the core. Addiction is a severe chronic disease and needs treatment and recovery. Organized crime undermines the rule of law, fuels violence, and threatens security. We don’t need a war on drugs or unregulated liberalization. Repression alone does not solve health problems. We need a balanced and determined approach addressing supply, demand, and harm, with human rights fully respected. Germany supports the EU Action Plan against organized crime and has launched a national program at the same time. We need to strengthen prevention, treatment, and harm reduction, with more substitution therapy, drug checking, and naloxone availability. This is evidence-based, responsible, and saves lives. Drug markets are increasingly digital, and criminal networks more sophisticated. Our response must be comprehensive and evidence-based.
Egypt: We are here to talk about our efforts to deal with the world drug problem, which is one of the biggest challenges we face. Methods are becoming more and more sophisticated. We support the statements from G77 and China and the African Group. We have an integrated national strategy across different bodies, ministries of foreign affairs, housing, and others. We work with CND in line with the international conventions. Our strategy focuses on reducing supply, including tackling online trafficking and money laundering. On demand reduction, different authorities run awareness campaigns, treatment programs, and reintegration initiatives. We provide treatment through dedicated centers and run outreach campaigns in schools and communities. I also want to announce our candidate for the CND election, who has spent his life combating drug trafficking. We support him and appeal to everyone to protect our society from the dangers of drugs.
ASEAN: we affirm our commitment to a drug‑free ASEAN. We are committed to controlling precursor chemicals. We support the CND and will continue to participate in its work, contributing to dialogue, consensus, and implementation of drug control commitments. ASEAN has zero tolerance for drugs. We coordinate regional drug policy, law enforcement, research, and alternative development, and identify areas to address in our drug activities. Drugs don’t respect borders, and their production, distribution, and trafficking require a coordinated response. We have mechanisms to enhance joint operations, training, and intelligence sharing among law enforcement agencies, through airports and seaports. In 2023, an IT system was launched to facilitate cooperation. We established ASEAN narcotics cooperation and created Asian Drug Monitoring Network to share information and develop the ASEAN Drug Monitoring Report. ASEAN recognizes the harm of drugs across the region. Drug abuse destroys lives, leading to addiction, poor health, and lost opportunities. To remember the lives lost, member states observe the ASEAN Victims Remembrance Day on 26 June, in conjunction with the International Day against Drug Abuse and Trafficking. This sends a sobering message and underscores ASEAN’s ongoing efforts to strengthen community resilience and raise awareness about the devastating impact of illicit drugs. There is growing momentum towards liberalized drug policies. This calls for a balanced, evidence‑based, science‑informed response that tackles both demand and supply, while protecting the rights of individuals and society to a safe, drug‑free environment, in accordance with international human rights and respecting national legislation. We reaffirm the Single Convention on Narcotic Drugs of 1961. Substances are scheduled based on scientific assessments of dependence potential and public health harm. We believe that substances such as coca leaf should remain in Schedule I unless clear, evidence-based justification exists for reclassification. Decisions based on national preferences risk undermining the integrity of the international drug control conventions.
Philippines: We use a comprehensive and balanced approach to address the world drug problem, mainly focused on supply reduction. Our priority is health, social, and development services, and we reinforce our commitment to a humane strategy. Communities are at the center of our efforts, with interventions starting at the grassroots level to empower citizens. Dangerous drugs are controlled and individuals affected by drug use are provided voluntary access to services. In 2025, the Drug Enforcement Agency conducted 39.000 anti-drug operations and seized drugs worth 48 billion pesos / 816 million dollars. We remain resolute in sustaining these efforts. Our goal is that people live in communities free from illegal drugs. We are concerned about new psychoactive substances and have established an early warning system to address them. We uphold dignity and full respect for human rights.
Austria: The difficult reality presented in the World Drug Report 2025 should serve as a reminder that constructive cooperation is needed to combat drug related crime. The conventions offer a solid foundation for action. Allow me to voice Austria’s strong support for the EU Framework through a whole government and whole society approach. Reflecting a shared commitment to drug supply, demand, and related harm reduction in compliance with the conventions and without stigma or discrimination. Our conviction that efforts to combat the world drug problem require evidence based and person oriented perspective. Treatment and harm reduction in line with the three main conventions are cornerstones of our approach but we need to also highlight prevention. Prevention in Austria starts in kindergarten and continues beyond that for all ages. We especially welcome the CHAMPS initiative and we actively support the initiative by organising a side-event to showcase what early intervention looks like in different countries and regions. We remain the proud host of the UNODC and reiterate commitment to diplomacy and the multilateral system.
Syrian Arab Republic: We support the statement from the G77 and China, and the Asia Pacific region. The 8th December 2024 is a critical date in the history of our country. This was not just a political regime change but it returned the rule of law and means we will now be combatting drugs. We have inherited a very difficult situation regarding infrastructure for production of industrial narcotics and distribution. Following the Assad regime we have adopted measures to dismantle the empire of captagon based on the principles of joint and shared responsibility. We have been able to dismantle this network and maintain efforts to combat this illegal trafficking. As you can see from the UNODC World Drug Report we have achieved a lot in a very short time especially regarding captagon and considering how serious the situation is. We are harnessing everyone in society to deal with this. We are not limiting efforts to situations we have inherited, we have adopted new strategies to deal specifically with synthetic drugs and paid attention to those who are suffering from drug use too. Identified cooperation with Jordan, Lebanon, Türkiye, and dismantled groups of criminal networks through working on 41 joint operations with those countries. We have used Arab League mechanisms and Council of Ministers of Interior. At the international level we have adopted a new policy based on transparency and cooperation to tackle the world drug problem. Working towards all the goals of the three main conventions and working with the international community, and regional and international partners. To conclude our battle against drugs is not one of security but of the future of young people and children, and to ensure Syria is a responsible international partner.
Mexico: New challenges require new responses from everyone especially given exponential growth of synthetics. This is more pressing for trends in geographic areas. We have submitted a Resolution to the CND including abuse and misuse of drugs and medicines, adaptation of production manufacturing, and use of precursors. In my country consumption has not reached alarming levels but we are not ignoring alarm bells from treatment cases, or that criminals are using their knowledge from decades working close to world markets to increase trafficking. We are promoting debate on the world drug problem including focus on public health, mental health, gender, development, and human rights. The main response to reduce domestic demand is intersectional strategy for prevention and mental health, granting priority to the structural causes and community based responses. We prioritise the wellbeing of people including through rehabilitation, reintegration, through non stigmatization. We also have a security policy to deal with transnational organised crime with respect for sovereignty and territorial integrity. The most recent operation resulted with the leader of the most powerful cartel being killed is evidence of our commitment to this struggle. Today the so-called fields in distant rural areas have become labs all over the world. The raw materials are now processed chemicals with designed precursors. Drugs are produced closer to consumers. Their name and colour is more important than origin and they are increasingly potent and lethal. There are efforts to reduce consumption and we are encouraged by action but we need to direct our efforts to abuse or misuse of drugs especially overprescription of drugs. Our experience is available as we have had low levels of addiction and consumption.
Iran: Our representative of the government couldn’t join us due to heinous actions against Iran. Ongoing actions, including killing schoolgirls and destruction of hospitals, by American and Israeli bombs can’t be justified under any circumstances. We align with G77 and China, as well as the Asia Pacific group. The world drug problem is evolving in increasingly complex and alarming ways. Despite sustained efforts we witness proliferation of new psychoactive substances, synthetic substances and precursors. Trafficking networks are employing sophisticated efforts. To address this problem, promotion of international cooperation is important and reinforcing exchange and intelligence sharing, improving early warning systems and sharing equipment and technologies are essential efforts of cooperation. A balanced response must be encouraged and improving access to substances for medical and scientific purposes should be a priority. Sharing of research findings and experiences should be facilitated. Regional programmes have been constrained or only partially operational and such initiatives need to be supported through predictable and adequate funding. Efforts to tackle the world drug problem unlawfully should be removed as these increase the financial burden for implementing programs and undermine frontline states to combat the world drug problem. We have adopted a balanced approach giving equal weight to supply and demand. Includes programmes for harm reduction and primary prevention. Seizing drugs, closing trafficking networks, and opening addiction treatment and harm reduction centers. We wished to share successful experiences in Iran at a side-event, but unfortunately this was cancelled due to war. Tackling the world drug problem is shared responsibility through multilateralism and sustained commitment to a brighter future for our society.
Russian Federation: The drug situation jeopardizes international stability and public health. The rise of synthetic drugs made from imported precursors threatens our efforts to build a drug-free society. In March, we proposed 4 mephedrone precursors and 1 methadone to be scheduled under international control, and we call on all members to support this. The international drug control system has proven effective and is now turning 65 years. Any steps to allow non-medical use or circulation of drugs are harmful to public safety and health and undermine international dialogue. Attempts by some countries to impose their own interpretation of the conventions are counterproductive, and we call for refraining and imposing enforcing so-called “harm reduction” that are not recognized or legislated in over half of the countries worldwide. We support returning to in-person meetings as soon as possible. We welcome the panel of experts and we nominated specialist Oksana Guseva to the panel. We continue to contribute through technical assistance. Our voluntary contributions around $3 million have supported training for anti-narcotics offices in Central Asia, Iraq, Pakistan, Egypt, and Africa. We also run programs for prevention, rehabilitation, and promoting healthy lifestyles among youth. We are grateful for cooperation that builds capacity in the Global South, ensures access to narcotic drugs for medical purposes, and promotes public safety and health.The streamlined actions, integrity and good faith of countries and implementing their obligations will determine whether lives are saved and public safety and health are upheld.
Zimbabwe: Zimbabwe aligns with G77 and China and African Group statements. We are committed to implementing international drug control treaties, promoting international cooperation, and multilateral efforts to tackle world drug problem. Past year, Zimbabwe has taken a comprehensive, multisectoral approach to reduce supply and demand, provide treatment and rehabilitation, and support reintegration of drug and substance abusers. Our efforts against drug trafficking included anti-drug operations that confiscated large quantities of illegal drugs and arrested over 3000 suspected suppliers per quarter. The availability of controlled substances in our country has been reduced. Demand reduction efforts focus on youth, with educational programs at all levels, psychosocial support, and initiatives to empower families and support reintegration. A draft bill to establish a Drug and Substance Abuse Control Agency is expected to be finalized before the end of the year. Zimbabwe remains committed to cooperating with the international community and maintaining a balance between controlling drugs and ensuring access for medical and scientific purposes.
Peru: addressing the world drug problem requires dynamic responses based on shared responsibility and considering the realities of each context. We need a solid pillar such as the three UN drug conventions, which Peru reaffirms commitment to and implements them comprehensively. Our national policy includes supply reduction, public health, alternative development, gender equality, protection of vulnerable communities, and environmental care. We value cooperation with allies like UNODC. Illicit crop monitoring helps us understand coca leaf dynamics and better eradicate it. In 2025, we eradicated over 36.000 hectares, reducing illicit coca crops for the second year in a row. Peru provides reliable data based on UNODC quality assurance system. We follow UN guidelines adopted in Lima in 2012 with Thailand and Germany. Peru also presented a draft resolution for an additional document to reduce illicit crops through sustainable economic opportunities. Political will and consistent implementation of the three conventions, and a comprehensive public policy, allow us to achieve results. We reaffirm CND as a priority for Peru and our commitment to building comprehensive policies to address the world drug problem, and we express confidence in the steps forward in this fight.
Chair: We reached the end of the first meeting. We have one more plenary meeting today and will start at 3pm as we want to conclude by 6pm today. Thank you, the meeting is adjourned.